Apimeds Pharmaceuticals US Earnings
NYSE: APUSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.60-0.14 (-8.05%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Apimeds Pharmaceuticals US earnings summary
In its most recent report on Nov 16, 2026 (Sep/2026), APUS posted EPS of $0.29. Across the last 6 reports, APUS shares moved an average of 15.6% (in either direction) in the first trading session after results, rising 1 times and falling 5 times.
Summary generated from market data by MetaCap's automated system. Methodology
APUS earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Nov 16, 2026 | — | $0.29 | — | — |
| Nov 11, 2026 | — | $-1.40 | — | -28.3% |
| Aug 14, 2026 | — | $-11.77 | — | +6.4% |
| May 26, 2026 | — | $-2.26 | — | -9.9% |
| Nov 12, 2025 | — | $-1.42 | — | -29.0% |
| Aug 19, 2025 | — | $-2.57 | — | -16.8% |
| May 20, 2025 | — | $-0.05 | — | -3.3% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.